Axcella Health Inc.
AXLA · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $56,984 | $43,135 | $37,039 | $41,658 |
| G&A Expenses | $15,815 | $18,711 | $16,797 | $15,781 |
| SG&A Expenses | $15,815 | $18,711 | $16,797 | $15,781 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$4 | $10 | $34 |
| Operating Expenses | $72,799 | $61,846 | $53,836 | $57,439 |
| Operating Income | -$72,799 | -$61,846 | -$53,836 | -$57,439 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$8,387 | -$2,782 | -$2,691 | -$1,598 |
| Pre-Tax Income | -$81,186 | -$64,628 | -$56,527 | -$59,037 |
| Tax Expense | $0 | $0 | $0 | $936 |
| Net Income | -$81,186 | -$67,118 | -$58,809 | -$59,973 |
| % Margin | – | – | – | – |
| EPS | -1.27 | -1.76 | -1.85 | -3.61 |
| % Growth | 27.8% | 4.9% | 48.8% | – |
| EPS Diluted | -1.27 | -1.76 | -1.85 | -3.61 |
| Weighted Avg Shares Out | 64,012 | 38,110 | 31,748 | 16,625 |
| Weighted Avg Shares Out Dil | 64,012 | 38,110 | 31,748 | 16,625 |
| Supplemental Information | – | – | – | – |
| Interest Income | $504 | $139 | $306 | $1,814 |
| Interest Expense | $3,021 | $2,917 | $3,007 | $3,395 |
| Depreciation & Amortization | $412 | $288 | $419 | $51 |
| EBITDA | -$77,753 | -$61,423 | -$53,101 | -$55,591 |
| % Margin | – | – | – | – |